Avoro Capital Advisors’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-416,666
| Closed | -$2.86M | – | 36 |
|
|
2024
Q2 | $2.86M | Hold |
416,666
| – | – | 0.04% | 40 |
|
|
2024
Q1 | $5.89M | Buy |
+416,666
| New | +$5.89M | 0.07% | 46 |
|
|
2022
Q2 | – | Sell |
-695,000
| Closed | -$9.11M | – | 42 |
|
|
2022
Q1 | $9.11M | Hold |
695,000
| – | – | 0.17% | 40 |
|
|
2021
Q4 | $12.2M | Hold |
695,000
| – | – | 0.21% | 37 |
|
|
2021
Q3 | $15.1M | Hold |
695,000
| – | – | 0.24% | 41 |
|
|
2021
Q2 | $24.3M | Sell |
695,000
-105,000
| -13% | -$3.68M | 0.42% | 36 |
|
|
2021
Q1 | $78.9M | Hold |
800,000
| – | – | 1.36% | 16 |
|
|
2020
Q4 | $86.7M | Hold |
800,000
| – | – | 1.49% | 17 |
|
|
2020
Q3 | $82.4M | Buy |
800,000
+41,500
| +5% | +$4.27M | 1.17% | 19 |
|
|
2020
Q2 | $158M | Buy |
758,500
+43,500
| +6% | +$9.08M | 3.13% | 11 |
|
|
2020
Q1 | $69.9M | Buy |
715,000
+190,000
| +36% | +$18.6M | 2.36% | 15 |
|
|
2019
Q4 | $60.5M | Buy |
525,000
+100,000
| +24% | +$11.5M | 1.78% | 16 |
|
|
2019
Q3 | $23.2M | Buy |
425,000
+75,000
| +21% | +$4.09M | 0.97% | 22 |
|
|
2019
Q2 | $41.6M | Buy |
+350,000
| New | +$41.6M | 1.44% | 17 |
|